Revvity (NYSE:RVTY) Shares Acquired Rep. Lisa C. McClain

Key Points

• Representative Lisa C. McClain recently acquired shares of Revvity Inc. (NYSE:RVTY) for an investment between $1,001 and $15,000, disclosed in a filing on August 13th.
• Revvity reported quarterly earnings of $1.18 per share, exceeding estimates by $0.04, with a revenue of $720.28 million, reflecting a year-over-year increase of 4.1%.
• The company declared a $0.07 quarterly dividend, with an annualized yield of 0.3%, scheduled for payment on November 7th to investors of record by October 17th.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Revvity Inc. NYSE: RVTY. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Revvity stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Revvity Stock Down 2.5%

RVTY stock traded down $2.3180 during mid-day trading on Monday, hitting $91.8320. 298,227 shares of the company were exchanged, compared to its average volume of 1,172,726. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33. The firm has a market cap of $10.66 billion, a P/E ratio of 38.92, a P/E/G ratio of 2.53 and a beta of 0.91. The firm's 50 day simple moving average is $94.57 and its 200 day simple moving average is $98.75. Revvity Inc. has a 1-year low of $85.12 and a 1-year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The company had revenue of $720.28 million during the quarter, compared to analysts' expectations of $711.26 million. During the same period last year, the business earned $1.22 EPS. The business's quarterly revenue was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, sell-side analysts predict that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity's dividend payout ratio is presently 11.86%.

Institutional Investors Weigh In On Revvity

A number of hedge funds have recently bought and sold shares of RVTY. CYBER HORNET ETFs LLC bought a new stake in shares of Revvity in the 2nd quarter worth approximately $32,000. Optiver Holding B.V. bought a new position in shares of Revvity in the fourth quarter worth about $33,000. Quarry LP increased its stake in Revvity by 45.7% during the fourth quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after acquiring an additional 95 shares during the period. MUFG Securities EMEA plc bought a new stake in shares of Revvity in the 2nd quarter valued at approximately $34,000. Finally, UMB Bank n.a. lifted its holdings in Revvity by 138.8% during the 2nd quarter. UMB Bank n.a. now owns 406 shares of the company's stock worth $39,000 after buying an additional 236 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on RVTY shares. Raymond James Financial restated an "outperform" rating and set a $115.00 price objective (down from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Robert W. Baird dropped their price target on Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. Bank of America lowered their target price on Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Evercore ISI decreased their price objective on Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Finally, UBS Group raised shares of Revvity from a "neutral" rating to a "buy" rating and dropped their price objective for the stock from $145.00 to $115.00 in a research note on Thursday, May 1st. Ten equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $120.07.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.